| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2016 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| N/A | 5 | Q3 2019 | 0.0% |
| iShares Russell 1000 Growth ETF | 3 | Q2 2018 | 14.6% |
| iShares Core US Aggregate Bond ETF | 3 | Q2 2018 | 12.7% |
| Vanguard Total International Bond ETF | 3 | Q2 2018 | 10.4% |
| iShares S&P 500 Growth ETF | 3 | Q2 2018 | 8.0% |
| SPDR Portfolio S&P 500 Growth ETF | 3 | Q2 2018 | 7.0% |
| Schwab US Large-Cap ETF (TM) | 3 | Q2 2018 | 6.6% |
| WisdomTree US LargeCap Dividend ETF | 3 | Q2 2018 | 5.6% |
| Schwab US Large-Cap Value ETF (TM) | 3 | Q2 2018 | 5.6% |
| Vanguard High Dividend Yield ETF | 3 | Q2 2018 | 5.5% |
View Delta Dental Plan of Michigan, Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. | May 17, 2019 | 1,265,802 | 12.7% |
| INTERLEUKIN GENETICS INC | October 11, 2016 | 10,928,961 | 4.8% |
View Delta Dental Plan of Michigan, Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-08 |
| 13F-HR | 2019-08-05 |
| 13F-HR | 2019-08-05 |
| 3 | 2019-05-17 |
| SC 13G | 2019-05-17 |
| 13F-HR | 2019-01-31 |
| 13F-HR | 2018-11-13 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-03-14 |
View Delta Dental Plan of Michigan, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.